2024 Southeastern Fracture Symposium

Elevate your practice with the latest techniques and best practices at the 2024 Southeastern Fracture Symposium! Our annual CME-accredited conference is designed specifically for orthopaedic trauma, featuring renowned leaders in orthopaedic trauma who will share their expertise and challenging cases. Engage in small group settings and participate in panel debates to directly interact with our speakers, and take advantage of ample time for questions and answers at each session. With a well-recognized research consortium group, our symposium offers unparalleled opportunities to stay ahead of the curve with cutting-edge research presented throughout conference presentations and publications. 

This year, dive into immersive hands-on lab sessions featuring cutting-edge tools, techniques, and innovation with dedicated two-hour focus sessions in the conference agenda. We will also be hosting a Thursday Afternoon cadaver lab event. Stay tuned for agenda updates and cadaver lab ticket availability.

 Don't miss out on this exceptional opportunity to advance your orthopaedic fracture care and management skills!

Click here to book your hotel reservation at The Francis Marion Hotel today and lock in the group rate for the conference!

Code: FRACTURE24

------------------------------------------------------------------------------------------------

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Orthopaedic Surgeons and The Southeastern Fracture Consortium. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.

The 2024 Southeastern Fracture Symposium will be certified for AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Current guidelines state that the participants in CME activities should be made aware of any affiliation or financial interests that may affect the speaker's presentation and/or the discussion of off-label therapies. Each speaker has been requested to complete a faculty disclosure statement. The names of speakers declaring potential conflict of interests or those who will be discussing any off-label, experimental or investigational use of drugs or devices in their presentations will be printed in the course syllabus.